Overview

Accelerated ART Initiation for PWHIV Who Are Out of Care

Status:
RECRUITING
Trial end date:
2026-11-01
Target enrollment:
Participant gender:
Summary
The main purpose of the study is to evaluate the effectiveness, of the ACCELERATE model of care to achieve HIV viral suppression at Week 24. The study will also assess the acceptability, appropriateness, feasibility, and sustainability of the ACCELERATE model of care. The ACCELERATE model combines a standardized method for outreach, the use of telehealth for rapid access to an HIV care provider, a simplified pre-approved HIV regimen, a free 30-day medication starter supply, and re-linkage to medical care.
Phase:
PHASE4
Details
Lead Sponsor:
University of Missouri-Columbia
Collaborator:
Gilead Sciences
Treatments:
bictegravir
Emtricitabine
tenofovir alafenamide